2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
04:30 p.m. - 06:00 p.m.
MCCNO - 291-292
Technology and Procedures, Assays, Imaging, Omics Technologies, Bioinformatics, Blood Banking, Cell Expansion, Gene Editing, Profiling, Biological Processes, Genomics, Hematopoiesis, Metabolism, Molecular Biology, Diseases, Genetic Disorders, Metabolic Disorders, Research, Fundamental Science, Translational Research, Study Population, Human, Adult
PAPER

979 Vesicle trafficking defects due to dominant negative VPS4A mutations cause increased autophagic activity in terminal erythropoiesis

Courtney Gatterdam, Aikaterini Voulgaridou, MD2, Ashley Kuenzi Davis3, Yi Zheng, PhD4, Theodosia M Kalfa Jr, MD, PhD5, Katie Seu, PhD6
1 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
2 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
3 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
4 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
5 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
6 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

Vacuolar Protein Sorting 4A (VPS4A) is a AAA-ATPase (ATPases Associated with diverse cellular Activities) that is recruited by the Endosomal Sorting Complex Required for Transport (ESCRT)-III machinery to sites of membrane remodeling and scission. It was first identified in yeast for its essential role in vacuolar transport and it is required for endolysosomal transport in mammalian cells as well as cytokinesis, nuclear envelope repair, and other functions requiring membrane scission. Pathogenic variants in the ATPase domain of VPS4A cause the multi-system syndrome CIMDAG (Cerebellar hypoplasia and cataracts, Impaired intellectual development, congenital Microcephaly, Dystonia, Anemia, and Growth retardation) with some patients presenting with severe, transfusion-dependent hemolytic and dyserythropoietic anemia with iron overload indicating ineffective erythropoiesis, while others have mild or subclinical anemia (Seu, et al. AJHG 2020; Rodger, Flex, and Allison, et al. AJHG 2020). 

We previously reported that erythroblasts with these mutations experience cytokinesis failure, due to loss of VPS4A activity in the abscission step of cytokinesis, contributing to the dyserythropoiesis phenotype. The patient phenotype also involved retention of CD71 on mature red blood cells suggesting that defects in vesicular trafficking might also play a role. To investigate the mechanisms leading to this erythroid maturation defect in some individuals with DN VPS4A variants, we performed bulk RNA sequencing of magnetically sorted CD71+ reticulocytes from the peripheral blood of patients and normal healthy controls. We observed increases in erythropoiesis- and iron-related genes in these individuals, corresponding with accelerated, albeit inefficient, erythropoiesis and dysfunctional trafficking of the transferrin receptor, CD71, as we have previously described. We also observed a marked increase in genes associated with autophagy including RB1CC1 (encoding FIP200) and ATG13 (ULK1 complex components involved in initiation); ATG2B (phagophore nucleation); the Atg8 homologs MAP1LC3B, GABARAPL1, and GABARAPL2 (elongation); ATG4A and ATG4D (Atg8/LC3 priming); TAX1BP1 and NBR1 (cargo recruitment); and STX17 (lysosomal fusion).

We hypothesized that autophagy may be upregulated as a compensatory mechanism to impaired vesicle trafficking. To investigate this possibility, we performed electron microscopy (EM) studies on CD71+ reticulocytes from patients and normal controls. Intracellular organellar structures were rare in normal control reticulocytes, therefore, we also used CD71+ reticulocytes from patients with reticulocytosis due to sickle cell disease to control for the immaturity of reticulocytes found in individuals with VPS4A mutations. VPS4A and ESCRT-III are especially important for formation of intraluminal vesicles in late endosomes, called multivesicular bodies (MVBs) and DN mutations in VPS4A have been shown to disrupt MVB formation and fusion with lysosomes. MVBs were found in reticulocytes from both normal controls and SCD samples but were rare in VPS4A mutant reticulocytes which had larger endolysosomal structures that were irregular in appearance. We also noted a paucity of mitochondria in the VPS4A-mutant reticulocytes, and increased appearance of autophagic membranes that were not as common in controls suggesting accelerated mitophagy in these reticulocytes.

Finally, in order to test the notion that DN VPS4A mutant cells have increased autophagic activity, we measured autophagic flux in EBV-immortalized lymphoblastoid lines from the patients at baseline and under starvation conditions. We found that steady state levels of LC3-II were significantly lower in the patient lines, but increased dramatically with addition of the lysosomal inhibitor BafA indicating rapid turnover of LC3-II and increased autophagic flux at baseline. Together, these data suggest that cells with DN VPS4A mutations induce autophagic activity to counteract the disrupted endolysosomal transport.  Future work will dissect the balance between vesicle transport and autophagy pathways at different stages of terminal erythropoiesis and the upstream signaling responsible for this activity.
Katie Seu, PhD: No relevant conflicts of interest to declare.